Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

[This corrects the article DOI: 10.3389/fphar.2020.575691.].

Uložené v:
Podrobná bibliografia
Vydané v:Frontiers in pharmacology Ročník 12; s. 630274
Hlavní autori: Honrao, Chandrashekhar, Ma, Xiaoyu, Kulkarni, Shashank, Joshi, Vinit, Malamas, Michael, Zvonok, Alexander, Wood, JodiAnne, Kautz, Roger A., Strand, David, Guo, Jason J., Makriyannis, Alexandros
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland Frontiers Media S.A 22.04.2021
Predmet:
Adamantyl metabolism
CYP3A4 metabolism
di-hydroxyl adamantyl metabolite
LC-MS
metabolite identification
micro-coil NMR
Pharmacology
CYP3A4 metabolism
LC-MS
CB2 agonist
di-hydroxyl adamantyl metabolite
micro-coil NMR
Adamantyl metabolism
metabolite identification
cannabinoid metabolism
ISSN:1663-9812, 1663-9812
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:[This corrects the article DOI: 10.3389/fphar.2020.575691.].
Bibliografia:corrigendum
ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
Deceased.
Approved by: Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.630274